Review

Factors Affecting Pathological Complete Response in Locally Advanced Breast Cancer Cases Receiving Neoadjuvant Therapy: A Comprehensive Literature Review
  • Munaser Alamoodi
Eur J Breast Health 2024; 20: 8-14 DOI: 10.4274/ejbh.galenos.2023.2023-11-2 PMID:38187111
Extended Sentinel Node Biopsy in Breast Cancer Patients who Achieve Complete Nodal Response with Neoadjuvant Chemotherapy
  • Alfredo Carlos Simões Dornellas de Barros
  • Danúbia Ariana de Andrade
Eur J Breast Health 2020; 16: 99-105 DOI: 10.5152/ejbh.2020.4730

Original Article

EVALUATİON OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY İN PATİENTS WİTH BREAST CANCER
  • Can Atalay
  • Niyazi Karaman
  • Kerim Bora Yılmaz
  • Mehmet Altınok
Eur J Breast Health 2007; 3: 26-30
Evaluation of Neoadjuvant Chemotherapy Response with Dynamic Contrast Enhanced Breast Magnetic Resonance Imaging in Locally Advanced Invasive Breast Cancer
  • Naciye Sinem Gezer
  • Ozge Orbay
  • Pinar Balcı
  • Merih Guray Durak
  • Binnaz Demirkan
  • Serdar Saydam
Eur J Breast Health 2014; 10: 111-118 DOI: 10.5152/tjbh.2014.2035
The Correlation of Magee EquationsTM and Oncotype DX® Recurrence Score From Core Needle Biopsy Tissues in Predicting Response to Neoadjuvant Chemotherapy in ER+ and HER2- Breast Cancer
  • Atilla Soran
  • Kaori Tane
  • Efe Sezgin
  • Rohit Bhargava
Eur J Breast Health 2020; 16: 117-123 DOI: 10.5152/ejbh.2020.5338
The Relationship of Pathological Response and Visceral Muscle and Fat Volume in Women With Breast Cancer Who Received Neoadjuvant Chemotherapy
  • Tuba Kayan Tapan
  • Filiz Çelebi
  • Kourosh Yaghouti
  • Filiz Ağaçayak
  • Serkan İlgün
  • Gürsel Soybir
  • Gül Alço
  • Naziye Ak
  • Çetin Ordu
  • Enver Özkurt
  • Çağlar Ünal
  • Sevgi Kurt
  • Alper Öztürk
  • Zeynep İyigün
  • Tomris Duymaz
  • Vahit Özmen
Eur J Breast Health 2024; 20: 117-121 DOI: 10.4274/ejbh.galenos.2024.2023-12-5
Clinicopathological Features of Breast Cancer with Polysomy 17 and Its Response to Neoadjuvant Chemotherapy
  • Hongxia Sun
  • Hui Chen
  • James Crespo
  • Guilin Tang
  • Melissa Robinson
  • Bora Lim
  • Ayşegül A. Şahin
Eur J Breast Health 2021; 17: 128-136 DOI: 10.4274/ejbh.galenos.2021.2021-2-9 PMID:33870112
Role of F-18 FDG PET/CT in Predicting Response to Neoadjuvant Chemotherapy in Invasive Ductal Breast Cancer
  • Tarik Sengoz
  • Yeliz Arman Karakaya
  • Aziz Gültekin
  • Sevda Yilmaz
  • Ergun Erdem
  • Burcu Yapar Taskoylu
  • Zehra Kesen
  • Olga Yaylali
  • Dogangun Yuksel
Eur J Breast Health 2023; 19: 159-165 DOI: 10.4274/ejbh.galenos.2023.2023-1-3 PMID:37025574
Evaluation of Pathologic Complete Response (pCR) to Neoadjuvant Chemotherapy in Iranian Breast Cancer Patients with Estrogen Receptor Positive and HER2 Negative and impact of predicting variables on pCR
  • Ramesh Omranipour
  • Roghiyeh Jalili
  • Adel Yazdankhahkenary
  • Abdolali Assarian
  • Mehrzad Mirzania
  • Bita Eslami
Eur J Breast Health 2020; 16: 213-218 DOI: 10.5152/ejbh.2020.5487
Inflammatory Markers Predicting Pathological Complete Response in Cases with Breast Cancer Treated by Neoadjuvant Chemotherapy
  • Mahmut Büyükşimşek
  • Ali Oğul
  • Cem Mirili
  • Semra Paydaş
Eur J Breast Health 2020; 16: 229-234 DOI: 10.5152/ejbh.2020.5556
An In Silico Analysis Identified Members of the Pleckstrin Homology-Like Domain, Family B (PHLDB family) as Potential Prognostic and Predictive Biomarkers of Treatment Response in Breast Cancer Patients
  • Renan Gomes do Nascimento
  • Jéssica de Moraes
  • Danilo de Oliveira Cerqueira
  • Sandro Jorge Januário
Eur J Breast Health 2022; 18: 235-247 DOI: 10.4274/ejbh.galenos.2022.2022-3-5 PMID:35855195
An Overview of the Impact of Body Mass Index on Pathological Complete Response Following Neoadjuvant Chemotherapy in Operable Breast Cancer in a Tertiary Care Centre in South India
  • SP Somashekhar
  • Richa Jaiswal
  • Rohit Kumar
  • BC Ashok
  • Susmita Rakshit
  • Amit Rauthan
  • Poonam Patil
  • Nitin Yashas
  • HK Karthik
  • Archa Prasad
  • Herra Islam
  • KR Ashwin
Eur J Breast Health 2022; 18: 271-278 DOI: 10.4274/ejbh.galenos.2022.2022-2-5 PMID:35855193

Original Articles

AXILLARY RESPONSE TO NEO-ADJUVAN CHEMOTHERAPY: DECREASE IN NUMBER OF LYMPH NODES
  • Erol Aksaz
  • Tayanç Oncel
  • Turay Yazıcı
  • Adil Aydemir
  • Sibel Bayer
  • Nuray İpek
Eur J Breast Health 2012; 8: 134-137
FACTORS AFFECTING DISEASE FREE AND OVERALL SURVIVAL IN PATIENTS WITH LOCALLY ADVANCED BREAST CANCER AFTER NEOADJUVANT CHEMOTHERAPHY (LABC) (THE 10-YEAR RESULTS)
  • Alper Öztürk
  • Atilla Bozdoğan
  • Derya Selamoğlu
  • Mahmut Müslümanoğlu
  • Abdullah İğci
  • Vahit Özmen
Eur J Breast Health 2012; 8: 138-145